The Guardian · US news · Original story
Supreme court allows abortion pill mifepristone to continue to be available by mail
Louisiana had sued the FDA in a bid to curtail the regulatory agency’s rules on prescribing mifepristone remotely
Sign up for the Breaking News US newsletter email
The US supreme court upheld nationwide access to mail-order mifepristone, an abortion medication, in a shadow-docket decision on Thursday.
Louisiana sued the US Food and Drug Administration (FDA) in October in a bid to curtail the regulatory agency’s rules on prescribing mifepristone remotely, arguing that it interfered with the state’s ban on abortion.
Continue reading...
Melody Schreiber · Thu, May 14, 2026, 2:38 PM
US news | The Guardian
Louisiana had sued the FDA in a bid to curtail the regulatory agency’s rules on prescribing mifepristone remotely
The US supreme court upheld nationwide access to mail-order mifepristone, an abortion medication, in a shadow-docket decision on Thursday.
Louisiana sued the US Food and Drug Administration (FDA) in October in a bid to curtail the regulatory agency’s rules on prescribing mifepristone remotely, arguing that it interfered with the state’s ban on abortion.
Continue reading...This page shows an excerpt; reporting belongs to the original publisher. Some images or embeds may be omitted compared with the live article.
← More stories · Front page